
Genetically engineered mosquitoes that have been under regulatory review for the past five years have passed one of the last remaining hurdles to gain approval for release in a field trial, the Food and Drug Administration announced Friday.
Oxitec’s OX513A Aedes aegypti mosquito would pose no significant threat to the environment or to people in Key Haven, a community in the Florida Keys where the company proposed the trial, the agency announced in a preliminary finding. The initial judgment of “no impact”…
GM mosquitoes clear an FDA hurdle for Florida release, locals angry
No comments:
Post a Comment